Disc Medicine(IRON),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

IRON Disc Medicine

Closed Good Friday 04-17 16:00:00 EDT

42.17

+1.17

+2.84%

盘后42.17

+0.000.00%

19:50 EDT

High42.46	Low40.69	Vol347.43K
Open40.84	D1 Closing41.00	Amplitude4.32%
Mkt Cap1.46B	Tradable Cap1.11B	Total Shares34.57M
T/O14.51M	T/O Rate1.32%	Tradable Shares26.30M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"IRON","market":"US","secType":"STK","nameCN":"Disc Medicine","latestPrice":42.165,"timestamp":1744920000000,"preClose":41,"halted":0,"volume":347426,"hourTrading":{"tag":"盘后","latestPrice":42.165,"preClose":42.165,"latestTime":"19:50 EDT","volume":11617,"amount":489830.625,"timestamp":1744933846345},"delay":0,"floatShares":26301475,"shares":34569042,"eps":-3.961345,"marketStatus":"Closed Good Friday","change":1.165,"latestTime":"04-17 16:00:00 EDT","open":40.84,"high":42.46,"low":40.69,"amount":14508301.3044,"amplitude":0.043171,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.961345,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"listingDate":1597204800000,"exchange":"NASDAQ","adjPreClose":41,"preHourTrading":{"tag":"盘前","latestPrice":40.9,"preClose":41,"latestTime":"08:33 EDT","volume":366,"amount":14930.970000000001,"timestamp":1744893216202},"postHourTrading":{"tag":"盘后","latestPrice":42.165,"preClose":42.165,"latestTime":"19:50 EDT","volume":11617,"amount":489830.625,"timestamp":1744933846345},"volumeRatio":0.7125647326561735,"optionData":{"bulkOrders":[{"symbol":"IRON","call":true,"expireDate":1747368000000,"strike":"50.0","timestamp":1744900478640,"price":0.35,"volume":1500,"amount":52500,"type":"-"}]},"impliedVol":0.6261,"impliedVolPercentile":0.3825},"requestUrl":"/m/hq/s/IRON","defaultTab":"news","newsList":[{"id":"2522858398","title":"Insider Shake-Up: Disc Medicine Directors Make Major Stock Moves!","url":"https://stock-news.laohu8.com/highlight/detail?id=2522858398","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522858398?lang=en_us&edition=full_marsco","pubTime":"2025-03-27 10:01","pubTimestamp":1743040916,"startTime":"0","endTime":"0","summary":"New insider activity at Disc Medicine ( ($IRON) ) has taken place on March 27, 2025. In a recent series of transactions, Director Mona Ashiya and D...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/insider-shake-up-disc-medicine-directors-make-major-stock-moves?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/insider-shake-up-disc-medicine-directors-make-major-stock-moves?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IRON","BK4139"],"gpt_icon":0},{"id":"2521203865","title":"With 65% ownership, Disc Medicine, Inc. (NASDAQ:IRON) boasts of strong institutional backing","url":"https://stock-news.laohu8.com/highlight/detail?id=2521203865","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521203865?lang=en_us&edition=full_marsco","pubTime":"2025-03-23 20:20","pubTimestamp":1742732448,"startTime":"0","endTime":"0","summary":"Given the large stake in the stock by institutions, Disc Medicine's stock price might be vulnerable to their trading decisions. 50% of the business is held by the top 9 shareholders. Every investor in Disc Medicine, Inc.  should be aware of the most powerful shareholder groups. With 65% stake, institutions possess the maximum shares in the company. Put another way, the group faces the maximum upside potential .Because institutional owners have a huge pool of resources and liquidity, their investing decisions tend to carry a great deal of weight, especially with individual investors. Therefore, a good portion of institutional money invested in the company is usually a huge vote of confidence on its future.In the chart below, we zoom in on the different ownership groups of Disc Medicine.The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. The company management answer to","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/65-ownership-disc-medicine-inc-122048190.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IRON","BK4585","BK4139","PSQ","TSYW.SI","LU2210150020.SGD","IE00BGHQF748.EUR","QID","IE00BKPKM429.USD","QLD","USAW.SI","NQmain","IE00B64PRP62.GBP","TQQQ","LU2095319765.USD","LU2210149790.SGD","MNQmain","NVIW.SI","IE00B3QW5Z07.USD","USJW.SI","NDAQ","SQQQ","BK4112",".IXIC","BK4588"],"gpt_icon":1},{"id":"2521639102","title":"Victoria's Secret, Bitdeer, and More Stocks See Activist Action -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2521639102","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521639102?lang=en_us&edition=full_marsco","pubTime":"2025-03-22 06:35","pubTimestamp":1742596500,"startTime":"0","endTime":"0","summary":"These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material is from March 13 through March 19, 2025. Source: VerityData. Algonquin Power  Starboard Value raised its stake in the utility company to 66,433,000 shares. Starboard Value did so through the purchase of 417,000 Algonquin Power shares from Jan. 13 through Feb. 3, 2025, at per share prices ranging from $4.20 to $4.33, but offset those purchases through the sale of 300,000 Algonquin shares on Feb. 19 at an average price of $4.96. On March 13, Starboard entered into an agreement with Algonquin to appoint Gavin Molinelli to the board immediately following approval by the Federal Energy Regulatory Commission.Victoria's Secret  BBRC International raised its stake in the women's lounge- and sleepwear maker to 9,","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USDT.USD.CC","BK4600","USDT.USD.HKCC","INVA","BK4094","BK4588","BK4095","BK4007","AQN","VSCO","BK4595","BK4585","VCCTF","BK4139","BK4208","BTDR","BK4023","LU1878469433.USD","IRON"],"gpt_icon":0},{"id":"2520467452","title":"Disc Medicine Is Maintained at Overweight by Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2520467452","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520467452?lang=en_us&edition=full_marsco","pubTime":"2025-03-18 21:12","pubTimestamp":1742303520,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IRON/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 18, 2025 09:12 ET (13:12 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRON"],"gpt_icon":0},{"id":"2520676626","title":"Disc Medicine price target raised to $132 from $99 at Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2520676626","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520676626?lang=en_us&edition=full_marsco","pubTime":"2025-03-18 20:28","pubTimestamp":1742300902,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald analyst Kristen Kluska raised the firm’s price target on Disc Medicine (IRON) to $132 from $99 and keeps an Overweight rating on ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/disc-medicine-price-target-raised-to-132-from-99-at-cantor-fitzgerald?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/disc-medicine-price-target-raised-to-132-from-99-at-cantor-fitzgerald?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IRON"],"gpt_icon":0},{"id":"2520676167","title":"Disc Medicine (IRON) Gets a Buy from Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2520676167","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520676167?lang=en_us&edition=full_marsco","pubTime":"2025-03-18 20:26","pubTimestamp":1742300803,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald analyst Kristen Kluska maintained a Buy rating on Disc Medicine (IRON – Research Report) yesterday and set a price target of $132...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/disc-medicine-iron-gets-a-buy-from-cantor-fitzgerald?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/disc-medicine-iron-gets-a-buy-from-cantor-fitzgerald?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IRON"],"gpt_icon":0},{"id":"2519233622","title":"All You Need to Know About Disc Medicine, Inc. (IRON) Rating Upgrade to Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2519233622","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519233622?lang=en_us&edition=full_marsco","pubTime":"2025-03-15 00:00","pubTimestamp":1741968024,"startTime":"0","endTime":"0","summary":"Disc Medicine, Inc.  appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 . This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.The power of a changing earnings picture in determining near-term stock price movements makes the Zacks rating system highly useful for individual investors, since it can be difficult to make decisions based on rating upgrades by Wall Street analysts. These are mostly driven by subjective factors that are hard to see and measure in real time.As such, the Zacks rating upgrade for Disc Medicine, Inc. is essentially a positive comment on its earnings outlook that could have a favorable impact on it","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/know-disc-medicine-inc-iron-160024889.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IRON"],"gpt_icon":0},{"id":"2517456875","title":"Disc Medicine Coverage Assumed by Morgan Stanley at Overweight","url":"https://stock-news.laohu8.com/highlight/detail?id=2517456875","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517456875?lang=en_us&edition=full_marsco","pubTime":"2025-03-08 01:35","pubTimestamp":1741368900,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IRON/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 07, 2025 12:35 ET (17:35 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRON"],"gpt_icon":0},{"id":"2517484516","title":"Analysts Offer Insights on Healthcare Companies: Denali Therapeutics (DNLI), Disc Medicine (IRON) and PTC Therapeutics (PTCT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517484516","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517484516?lang=en_us&edition=full_marsco","pubTime":"2025-03-07 20:12","pubTimestamp":1741349542,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Denali Therapeutics (DNLI – Research Report), Disc M...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-denali-therapeutics-dnli-disc-medicine-iron-and-ptc-therapeutics-ptct?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-denali-therapeutics-dnli-disc-medicine-iron-and-ptc-therapeutics-ptct?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DNLI","LU2506952410.USD","LU1721428347.USD","BK4585","LU0889565916.HKD","PTC","LU1923623000.USD","BK4588","PTCT","BK4139","LU2362540622.SGD","LU2506952337.HKD","BK4554","LU0320765992.SGD","LU1951198990.SGD","BK4548","LU2362541513.USD","LU2477742899.HKD","BK4023","IRON","BK4137","BK4535","LU0109394709.USD","HCSG","LU2362541273.HKD","BK4576","LU1951200564.SGD"],"gpt_icon":0},{"id":"2516637102","title":"Disc Medicine Is Maintained at Sector Outperform by Scotiabank","url":"https://stock-news.laohu8.com/highlight/detail?id=2516637102","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516637102?lang=en_us&edition=full_marsco","pubTime":"2025-03-03 23:12","pubTimestamp":1741014720,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IRON/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 03, 2025 10:12 ET (15:12 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRON"],"gpt_icon":0},{"id":"2516653196","title":"Wall Street Analysts Predict a 68.78% Upside in Disc Medicine, Inc. (IRON): Here's  What You Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2516653196","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516653196?lang=en_us&edition=full_marsco","pubTime":"2025-03-03 22:55","pubTimestamp":1741013710,"startTime":"0","endTime":"0","summary":"Shares of Disc Medicine, Inc.  have gained 0.7% over the past four weeks to close the last trading session at $56.18, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $94.82 indicates a potential upside of 68.8%.The average comprises 11 short-term price targets ranging from a low of $73 to a high of $118, with a standard deviation of $13.84. While the lowest estimate indicates an increase of 29.9% from the current price level, the most optimistic estimate points to an 110% upside. More than the range, one should note the standard deviation here, as it helps understand the variability of the estimates. The smaller the standard deviation, the greater the agreement among analysts.That said, while investors should not entirely ignore price targets, making an investment decision solely based on them could lead to disappointing ROI. So, pric","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/wall-street-analysts-predict-68-145510219.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IRON","BK4139"],"gpt_icon":0},{"id":"2516618632","title":"Disc Medicine price target raised to $75 from $73 at Scotiabank","url":"https://stock-news.laohu8.com/highlight/detail?id=2516618632","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516618632?lang=en_us&edition=full_marsco","pubTime":"2025-03-03 22:41","pubTimestamp":1741012891,"startTime":"0","endTime":"0","summary":"Scotiabank analyst Greg Harrison raised the firm’s price target on Disc Medicine (IRON) to $75 from $73 and keeps an Outperform rating on the share...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/disc-medicine-price-target-raised-to-75-from-73-at-scotiabank?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/disc-medicine-price-target-raised-to-75-from-73-at-scotiabank?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IRON"],"gpt_icon":0},{"id":"2514403953","title":"Promising Prospects for Disc Medicine: Buy Rating Backed by Bitopertin’s Potential and Strong Financial Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2514403953","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514403953?lang=en_us&edition=full_marsco","pubTime":"2025-02-28 19:26","pubTimestamp":1740741974,"startTime":"0","endTime":"0","summary":"Douglas Tsao, an analyst from H.C. Wainwright, reiterated the Buy rating on Disc Medicine (IRON – Research Report). The associated price target rem...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-prospects-for-disc-medicine-buy-rating-backed-by-bitopertins-potential-and-strong-financial-health?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-prospects-for-disc-medicine-buy-rating-backed-by-bitopertins-potential-and-strong-financial-health?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IRON"],"gpt_icon":0},{"id":"2514426399","title":"Disc Medicine’s 2024 Financial Results and Clinical Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2514426399","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514426399?lang=en_us&edition=full_marsco","pubTime":"2025-02-28 13:11","pubTimestamp":1740719516,"startTime":"0","endTime":"0","summary":"Disc Medicine, Inc. ( ($IRON) ) has released its Q4 earnings. Here is a breakdown of the information Disc Medicine, Inc. presented to its investors...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/disc-medicines-2024-financial-results-and-clinical-progress?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/disc-medicines-2024-financial-results-and-clinical-progress?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRGS","BK4097","BK4139","LU2065732104.USD","IRON"],"gpt_icon":0},{"id":"2514938323","title":"Disc Medicine's Annual Loss Widens in 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2514938323","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514938323?lang=en_us&edition=full_marsco","pubTime":"2025-02-27 22:32","pubTimestamp":1740666731,"startTime":"0","endTime":"0","summary":"Disc Medicine  reported a 2024 loss Thursday of $3.96 per share, wider than a loss of $3.42 a year earlier.Analysts polled by FactSet expected a loss of $4.13.As expected, no revenue was reported.As of Dec. 31, the company had $489.9 million in cash, cash equivalents and marketable securities. Combined with $243.3 million from an underwritten public offering, the company said it expects this will fund its operations into 2028.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IRON","BK4139"],"gpt_icon":0},{"id":"2514802526","title":"Earnings Flash (IRON) Disc Medicine Posts Full Year 2024 Net Loss $-3.96 a Share, vs. FactSet Est of $-4.23 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2514802526","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514802526?lang=en_us&edition=full_marsco","pubTime":"2025-02-27 21:20","pubTimestamp":1740662439,"startTime":"0","endTime":"0","summary":"Earnings Flash (IRON) Disc Medicine Posts Full Year 2024 Net Loss $-3.96 a Share, vs. FactSet Est of $-4.23 Loss","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IRON"],"gpt_icon":0},{"id":"2514804417","title":"Disc Medicine FY 2024 GAAP EPS $(3.96) Beats $(4.38) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2514804417","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514804417?lang=en_us&edition=full_marsco","pubTime":"2025-02-27 21:12","pubTimestamp":1740661922,"startTime":"0","endTime":"0","summary":"Disc Medicine FY 2024 GAAP EPS $(3.96) Beats $(4.38) Estimate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/02/44004779/disc-medicine-fy-2024-gaap-eps-3-96-beats-4-38-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Disc Medicine FY 2024 GAAP EPS $(3.96) Beats $(4.38) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRON"],"gpt_icon":0},{"id":"2514671804","title":"TD Cowen Initiates Coverage on Disc Medicine With Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2514671804","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514671804?lang=en_us&edition=full_marsco","pubTime":"2025-02-27 21:07","pubTimestamp":1740661664,"startTime":"0","endTime":"0","summary":"Disc Medicine (IRON) has an average rating of buy and mean price target of $93.55, according to analysts polled by FactSet.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TD","COWN","IRON"],"gpt_icon":0},{"id":"2514680140","title":"Disc Medicine FY Basic EPS USD -3.96 VS. Ibes Estimate USD -4.14","url":"https://stock-news.laohu8.com/highlight/detail?id=2514680140","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514680140?lang=en_us&edition=full_marsco","pubTime":"2025-02-27 21:00","pubTimestamp":1740661200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nPLXCA6EC2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IRON","BK4139"],"gpt_icon":0},{"id":"2514791801","title":"Press Release: Disc Medicine Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2514791801","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514791801?lang=en_us&edition=full_marsco","pubTime":"2025-02-27 21:00","pubTimestamp":1740661200,"startTime":"0","endTime":"0","summary":"-- Targeting NDA submission for bitopertin in erythropoietic protoporphyria.  in H2 2025 through accelerated approval pathway; on track to. -- Positive update from Phase 1b trial of DISC-0974 in patients with anemia. of myelofibrosis  presented at ASH 2024; initial data from ongoing. -- Positive data from initial cohorts of ongoing Phase 1b study of DISC-0974. in patients with anemia of non-dialysis-dependent chronic kidney disease.  presented at ASN Kidney Week 2024; initial data from multiple. -- Presented first-in-human SAD/MAD data from Phase 1 trial of DISC-3405. demonstrating proof-of-mechanism; a Phase 2 study in polycythemia vera. -- Strong financial position ending 2024 with $490 million in cash, cash. equivalents, and marketable securities, further strengthened by the net. proceeds of our public offering in January 2025, expected to fund. WATERTOWN, Mass., Feb. 27, 2025  -- Disc Medicine, Inc. , a clinical-stage biopharmaceutical company focused on the discovery, development,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRON","BK4582","BK4139","EPP"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.discmedicine.com","stockEarnings":[{"period":"1week","weight":0.1968},{"period":"1month","weight":-0.2019},{"period":"3month","weight":-0.2761},{"period":"6month","weight":-0.166},{"period":"1year","weight":0.3925},{"period":"ytd","weight":-0.3349}],"compareEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":-0.0617},{"period":"3month","weight":-0.1191},{"period":"6month","weight":-0.0995},{"period":"1year","weight":0.0517},{"period":"ytd","weight":-0.1018}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Disc Medicine Opco Inc, together with its subsidiaries, operates as a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. The company builds a portfolio of fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. It also develops bitopertin for the treatment of erythropoietic porphyrias, erythropoietic protoporphyria, and X-linked protoporphyria. In addition, the company develops DISC-0974 for the treatment of chronic kidney disease; MWTX-003 for the treatment of polycythemia vera, and other hematologic disorders; and DISC-0998 for the treatment of anemia associated with inflammatory. The company is based in Watertown, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.025839},{"month":2,"riseRate":0.8,"avgChangeRate":0.03392},{"month":3,"riseRate":0.2,"avgChangeRate":-0.08973},{"month":4,"riseRate":0.4,"avgChangeRate":-0.041954},{"month":5,"riseRate":0.75,"avgChangeRate":0.063441},{"month":6,"riseRate":0.75,"avgChangeRate":0.092417},{"month":7,"riseRate":0.25,"avgChangeRate":-0.09772},{"month":8,"riseRate":1,"avgChangeRate":0.116734},{"month":9,"riseRate":0.4,"avgChangeRate":-0.029361},{"month":10,"riseRate":0.2,"avgChangeRate":-0.036329},{"month":11,"riseRate":0.6,"avgChangeRate":0.061015},{"month":12,"riseRate":0.8,"avgChangeRate":0.070684}],"exchange":"NASDAQ","name":"Disc Medicine","nameEN":"Disc Medicine"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Disc Medicine(IRON),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Disc Medicine(IRON) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Disc Medicine,IRON,Disc Medicine股票,Disc Medicine股票老虎,Disc Medicine股票老虎国际,Disc Medicine行情,Disc Medicine股票行情,Disc Medicine股价,Disc Medicine股市,Disc Medicine股票价格,Disc Medicine股票交易,Disc Medicine股票购买,Disc Medicine股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Disc Medicine(IRON),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Disc Medicine(IRON) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction